ERD

CAST | Active Monitoring of Cancer As An Alternative To Surgery

01-11-2019

-

31-10-2024

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

CanPathPro | Generation of the CanPath prototype - a platform for predictive cancer pathway modeling

01-03-2016

-

30-11-2021

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

MoTriColor | Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor)

01-10-2015

-

30-11-2020

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

PragmaTIL | Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors

01-04-2023

-

31-03-2028

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

CARE1 | First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma

01-05-2023

-

30-04-2028

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

APERIM | APERIM: Advanced bioinformatics platform for PERsonalised cancer IMmunotherapy

01-05-2015

-

30-04-2018

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

CAPABLE | CAncer PAtients Better Life Experience

01-01-2020

-

31-01-2024

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

HoloSurge | Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers

01-01-2024

-

31-12-2027

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

B-CAST | Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes

01-09-2015

-

28-02-2021

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

ONCOVALUE | Implementing value-based oncology care at European cancer hospitals: An AI-based framework for assessing real-life effectiveness of novel cancer therapies in real-time

01-12-2022

-

30-11-2026

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

DNAREPAIRMAN | Regulated Assembly of Molecular Machines for DNA REPAIR: a Molecular Analysis training Network

01-01-2017

-

31-12-2020

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

SYNTRAIN | Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network

01-09-2016

-

30-11-2020

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

CCE_DART | Building Data Rich Clinical Trials

01-02-2021

-

31-01-2025

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

PREFERABLE-II | PREFERABLE-II - Personalised Exercise-Oncology for improvement of supportive care: a super umbrella trial to demonstrate the (cost)effectiveness of live-remote exercise in cancer survivors

01-11-2022

-

31-10-2027

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

West-Life | World-wide E-infrastructure for structural biology

01-11-2015

-

31-10-2018

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

H2020MM04 | DC-based immunotherapy to treat Malignant Mesothelioma

01-01-2016

-

31-12-2021

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

flIMAGIN3D | Doctoral Network for a Shared Excellence of Fluorescent Lifetime Imaging Microscopy in Biomedical Applications

01-01-2023

-

31-12-2026

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

PREFERABLE | Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

01-01-2019

-

30-06-2024

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

STEPUPIORS | TWINNING FOR A EUROPEAN CONSORTIUM OF RECTAL CANCER RESEARCH INSTITUTIONS THROUGH STEPPING UP SCIENTIFIC, TECHNOLOGICAL AND INNOVATION EXCELLENCE OF IORS

01-10-2022

-

30-09-2025

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

STREXIT2 | A PRAGMATIC CLINICAL STUDY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR PATIENTS WITH HIGH RISK RETROPERITONEAL SARCOMA

01-06-2023

-

31-05-2028

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

Cancer-Recurrence | Tumor cell death supports recurrence of cancer

01-09-2015

-

31-08-2020

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

ESPERANCE | ERA Chair Life Sciences Program to EmpoweR moleculAr aNd struCtural biology initiativEs at UPAT

01-02-2023

-

31-01-2028

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

Cat4CanCenter | Catalysis for Cancer Treatment.

01-01-2024

-

31-12-2029

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

OncoFetal_Ploidy | Understanding aneuploidy tolerance in cancer by studying early embryogenesis

01-07-2022

-

30-11-2024

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

CRADLE | Cancer treatment during pregnancy: from fetal safety to maternal efficacy

01-10-2015

-

31-03-2021

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

OVADEX | Defining the role of the tumor microenvironment in treatment resistance of OVArian cancer through patient-Derived EXplants (OVADEX)

01-09-2022

-

31-08-2024

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

GlioSurg | Role of astrogliosis in the recurrence of brain tumors after microsurgical resection

01-10-2022

-

30-09-2024

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

SENSIT | Sensitivity of human tumors to T cell attack

01-12-2017

-

30-11-2022

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

BURSTREG | Single-molecule visualization of transcription dynamics to understand regulatory mechanisms of transcriptional bursting and its effects on cellular fitness

01-01-2018

-

31-12-2022

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

Breakborder | Breaking borders, Functional genetic screens of structural regulatory DNA elements

01-09-2019

-

31-08-2024

Show more information

Organisation STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS (NKI)

Projects overview

Selected filters:

CAST | Active Monitoring of Cancer As An Alternative To Surgery

CanPathPro | Generation of the CanPath prototype - a platform for predictive cancer pathway modeling

MoTriColor | Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor)

PragmaTIL | Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors

CARE1 | First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma

APERIM | APERIM: Advanced bioinformatics platform for PERsonalised cancer IMmunotherapy

CAPABLE | CAncer PAtients Better Life Experience

HoloSurge | Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers

B-CAST | Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes

ONCOVALUE | Implementing value-based oncology care at European cancer hospitals: An AI-based framework for assessing real-life effectiveness of novel cancer therapies in real-time

DNAREPAIRMAN | Regulated Assembly of Molecular Machines for DNA REPAIR: a Molecular Analysis training Network

SYNTRAIN | Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network

CCE_DART | Building Data Rich Clinical Trials

PREFERABLE-II | PREFERABLE-II - Personalised Exercise-Oncology for improvement of supportive care: a super umbrella trial to demonstrate the (cost)effectiveness of live-remote exercise in cancer survivors

West-Life | World-wide E-infrastructure for structural biology

H2020MM04 | DC-based immunotherapy to treat Malignant Mesothelioma

flIMAGIN3D | Doctoral Network for a Shared Excellence of Fluorescent Lifetime Imaging Microscopy in Biomedical Applications

PREFERABLE | Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

STEPUPIORS | TWINNING FOR A EUROPEAN CONSORTIUM OF RECTAL CANCER RESEARCH INSTITUTIONS THROUGH STEPPING UP SCIENTIFIC, TECHNOLOGICAL AND INNOVATION EXCELLENCE OF IORS

STREXIT2 | A PRAGMATIC CLINICAL STUDY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR PATIENTS WITH HIGH RISK RETROPERITONEAL SARCOMA

Cancer-Recurrence | Tumor cell death supports recurrence of cancer

ESPERANCE | ERA Chair Life Sciences Program to EmpoweR moleculAr aNd struCtural biology initiativEs at UPAT

Cat4CanCenter | Catalysis for Cancer Treatment.

OncoFetal_Ploidy | Understanding aneuploidy tolerance in cancer by studying early embryogenesis

CRADLE | Cancer treatment during pregnancy: from fetal safety to maternal efficacy

OVADEX | Defining the role of the tumor microenvironment in treatment resistance of OVArian cancer through patient-Derived EXplants (OVADEX)

GlioSurg | Role of astrogliosis in the recurrence of brain tumors after microsurgical resection

SENSIT | Sensitivity of human tumors to T cell attack

BURSTREG | Single-molecule visualization of transcription dynamics to understand regulatory mechanisms of transcriptional bursting and its effects on cellular fitness

Breakborder | Breaking borders, Functional genetic screens of structural regulatory DNA elements